Export 15 results:
Author Title Type [ Year(Asc)]
Filters: Author is Sharma, Gaurav  [Clear All Filters]
2020
A. J. Donoghue, Kou, M., Good, G. L., Eiger, C., Nash, M., Henretig, F. M., Stacks, H., Kochman, A., Debski, J., Chen, J. - Y., Sharma, G., Hornik, C. P., Gosnell, L., Siegel, D., Krug, S., and Adler, M. D., “Impact of Personal Protective Equipment on Pediatric Cardiopulmonary Resuscitation Performance: A Controlled Trial.”, Pediatr Emerg Care, vol. 36, no. 6, pp. 267-273, 2020.
M. D. Adler, Krug, S., Eiger, C., Good, G. L., Kou, M., Nash, M., Henretig, F. M., Hornik, C. P., Gosnell, L., Chen, J. - Y., Debski, J., Sharma, G., Siegel, D., and Donoghue, A. J., “Impact of Personal Protective Equipment on the Performance of Emergency Pediatric Tasks.”, Pediatr Emerg Care, 2020.
M. Kou, Donoghue, A. J., Stacks, H., Kochman, A., Semião, M., Nash, M., Siegel, D., Ku, L., Debski, J., Chen, J. - Y., Sharma, G., Gosnell, L., Krug, S., and Adler, M. D., “Impact of Personal Protective Equipment on the Performance of Emergency Pediatric Procedures by Prehospital Providers.”, Disaster Med Public Health Prep, pp. 1-8, 2020.
2019
A. Adam, Schwartz, R. P., Wu, L. - T., Subramaniam, G., Laska, E., Sharma, G., Mili, S., and McNeely, J., “Electronic self-administered screening for substance use in adult primary care patients: feasibility and acceptability of the tobacco, alcohol, prescription medication, and other substance use (myTAPS) screening tool.”, Addict Sci Clin Pract, vol. 14, no. 1, p. 39, 2019.
2017
L. - T. Wu, McNeely, J., Subramaniam, G. A., Brady, K. T., Sharma, G., VanVeldhuisen, P., Zhu, H., and Schwartz, R. P., “DSM-5 substance use disorders among adult primary care patients: Results from a multisite study.”, Drug Alcohol Depend, vol. 179, pp. 42-46, 2017.
J. Gryczynski, McNeely, J., Wu, L. - T., Subramaniam, G. A., Svikis, D. S., Cathers, L. A., Sharma, G., King, J., Jelstrom, E., Nordeck, C. D., Sharma, A., Mitchell, S. G., O'Grady, K. E., and Schwartz, R. P., “Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care.”, J Gen Intern Med, vol. 32, no. 9, pp. 990-996, 2017.
2016
L. - T. Wu, McNeely, J., Subramaniam, G. A., Sharma, G., VanVeldhuisen, P., and Schwartz, R. P., “Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool.”, Contemp Clin Trials, vol. 50, pp. 90-7, 2016.
G. Sharma, Oden, N., VanVeldhuisen, P. C., and Bogenschutz, M. P., “Hair analysis and its concordance with self-report for drug users presenting in emergency department.”, Drug Alcohol Depend, vol. 167, pp. 149-55, 2016.
J. McNeely, Wu, L. - T., Subramaniam, G., Sharma, G., Cathers, L. A., Svikis, D., Sleiter, L., Russell, L., Nordeck, C., Sharma, A., O'Grady, K. E., Bouk, L. B., Cushing, C., King, J., Wahle, A., and Schwartz, R. P., “Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients.”, Ann Intern Med, vol. 165, no. 10, pp. 690-699, 2016.
L. J. Mooney, Hillhouse, M. P., Thomas, C., Ang, A., Sharma, G., Terry, G., Chang, L., Walker, R., Trivedi, M., Croteau, D., Sparenborg, S., and Ling, W., “Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder.”, J Addict Med, vol. 10, no. 4, pp. 236-43, 2016.
2014
E. A. McClure, Sonne, S. C., Winhusen, T., Carroll, K. M., Ghitza, U. E., McRae-Clark, A. L., Matthews, A. G., Sharma, G., Van Veldhuisen, P., Vandrey, R. G., Levin, F. R., Weiss, R. D., Lindblad, R., Allen, C., Mooney, L. J., Haynes, L., Brigham, G. S., Sparenborg, S., Hasson, A. L., and Gray, K. M., “Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network.”, Contemp Clin Trials, vol. 39, no. 2, pp. 211-23, 2014.
M. P. Bogenschutz, Donovan, D. M., Mandler, R. N., Perl, H. I., Forcehimes, A. A., Crandall, C., Lindblad, R., Oden, N. L., Sharma, G., Metsch, L., Lyons, M. S., McCormack, R., Macias-Konstantopoulos, W., and Douaihy, A., “Brief intervention for patients with problematic drug use presenting in emergency departments: a randomized clinical trial.”, JAMA Intern Med, vol. 174, no. 11, pp. 1736-45, 2014.
T. M. Winhusen, Kropp, F., Lindblad, R., Douaihy, A., Haynes, L., Hodgkins, C., Chartier, K., Kampman, K. M., Sharma, G., Lewis, D. F., VanVeldhuisen, P., Theobald, J., May, J., and Brigham, G. S., “Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence.”, J Clin Psychiatry, vol. 75, no. 7, pp. 757-64, 2014.
2012
T. Winhusen, Stitzer, M., Woody, G., Brigham, G., Kropp, F., Ghitza, U., Lindblad, R., Adinoff, B., Green, C., Sharma, G., and Somoza, E., “Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals.”, Contemp Clin Trials, vol. 33, no. 1, pp. 197-205, 2012.
T. Winhusen, Brady, K. T., Stitzer, M., Woody, G., Lindblad, R., Kropp, F., Brigham, G., Liu, D., Sparenborg, S., Sharma, G., VanVeldhuisen, P., Adinoff, B., and Somoza, E., “Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world.”, Contemp Clin Trials, vol. 33, no. 5, pp. 993-1002, 2012.